Brookdale Senior Living (BKD) Receives a Buy from RBC Capital
RBC Capital analyst Ben Hendrix reiterated a Buy rating on Brookdale Senior Living today and set a price target of $17.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hendrix covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, CVS Health, and Acadia Healthcare. According to TipRanks, Hendrix has an average return of 5.1% and a 55.04% success rate on recommended stocks.
In addition to RBC Capital, Brookdale Senior Living also received a Buy from Bank of America Securities’s Joanna Gajuk in a report issued today. However, on January 30, TipRanks – Google downgraded Brookdale Senior Living (NYSE: BKD) to a Hold.
Based on Brookdale Senior Living’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $777.84 million and a GAAP net loss of $114.73 million. In comparison, last year the company earned a revenue of $746.41 million and had a GAAP net loss of $50.72 million
Read More on BKD:
Disclaimer & DisclosureReport an Issue
- Brookdale Senior Living price target raised to $18 from $15.50 at BofA
- Brookdale Senior Living price target raised to $17 from $13 at RBC Capital
- Brookdale Senior Living price target raised to $15.50 from $13 at BofA
- Brookdale Senior Living Issues Upbeat 2025 Preliminary Outlook
- Brookdale Senior Living sees 2025 revenue $3.2B, consensus $3.19B
